scholarly article | Q13442814 |
P2093 | author name string | Bing Zhang | |
Baorui Liu | |||
Bin Zhu | |||
Xiaoyan Xin | |||
Huizi Sha | |||
Jingtao Shen | |||
P2860 | cites work | A caged lanthanide complex as a paramagnetic shift agent for protein NMR. | Q30342068 |
Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd(III) chelates | Q33580772 | ||
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs | Q33897492 | ||
Targeted probes for cardiovascular MRI | Q33901726 | ||
Molecular imaging in cancer | Q34530970 | ||
Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach | Q34634376 | ||
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET. | Q34648047 | ||
Tumor-penetrating iRGD peptide inhibits metastasis | Q34978216 | ||
Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 | ||
High-performance nanostructured MR contrast probes | Q35031050 | ||
Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers | Q36952035 | ||
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy | Q37224751 | ||
Targeting tumors with nanobodies for cancer imaging and therapy. | Q38137610 | ||
Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy | Q39399346 | ||
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression | Q40009259 | ||
A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. | Q40538607 | ||
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers | Q42925153 | ||
Versatile and selective synthesis of "click chemistry" compatible heterobifunctional poly(ethylene glycol)s possessing azide and alkyne functionalities | Q43193245 | ||
Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging | Q43283369 | ||
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography | Q43561095 | ||
Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide | Q45008593 | ||
MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides | Q45068701 | ||
P433 | issue | 6 | |
P304 | page(s) | 3227-3235 | |
P577 | publication date | 2016-03-29 | |
P1433 | published in | Oncology Reports | Q7092098 |
P1476 | title | Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI | |
P478 | volume | 35 |
Q58781545 | Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment |
Q48550017 | Dual-Targeted Molecular Imaging of Cancer |
Q91793873 | Imaging strategies in the management of gastric cancer: current role and future potential of MRI |
Q92336348 | Using Omniscan-Loaded Nanoparticles as a Tumor-Targeted MRI Contrast Agent in Oral Squamous Cell Carcinoma by Gelatinase-Stimuli Strategy |
Q92187150 | iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers |